These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2533901)

  • 1. Pharmaceutical development of ondansetron tablets.
    Leak RE; Woodford JD
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S63-6. PubMed ID: 2533901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical development of ondansetron injection.
    Leak RE; Woodford JD
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S67-9. PubMed ID: 2533902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
    Sheshala R; Khan N; Chitneni M; Darwis Y
    Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y; Huang G; Yu Y; Han J; Yu P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical pharmacology of ondansetron.
    Blackwell CP; Harding SM
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S21-4; discussion S25-7. PubMed ID: 2533895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E; Antal B; Zsadon B; Szejtli J
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the mechanism for paradoxical effect of ionized and unionized chitosan: Orodispersible tablets of Ondansetron Hydrochloride.
    Goel H; Vora N; Tiwary AK; Rana V
    Pharm Dev Technol; 2009; 14(5):476-84. PubMed ID: 19241220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron.
    Hassan N; Khar RK; Ali M; Ali J
    AAPS PharmSciTech; 2009; 10(4):1085-92. PubMed ID: 19757080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients.
    Fathy M; Hassan MA; Mohamed FA
    Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of microorganisms in some common excipients used in tablet formulation.
    Obuekwe IF; Eichie F
    Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of the properties of compacts from a mixed dry binder on the base of alpha-lactose monohydrate and microcrystalline cellulose].
    Muzíková J; Páleník L
    Ceska Slov Farm; 2005 May; 54(3):118-22. PubMed ID: 15945458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized regression neural networks in prediction of drug stability.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L; Lucić B
    J Pharm Pharmacol; 2007 May; 59(5):745-50. PubMed ID: 17524242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride.
    Yamamura T; Ohta T; Taira T; Ogawa Y; Sakai Y; Moribe K; Yamamoto K
    Int J Pharm; 2009 Mar; 370(1-2):1-7. PubMed ID: 19059327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
    Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of ondansetron hydrochloride in syrups compounded from tablets.
    Williams CL; Sanders PL; Laizure SC; Stevens RC; Fox JL; Hak LJ
    Am J Hosp Pharm; 1994 Mar; 51(6):806-9. PubMed ID: 8010321
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of direct compression excipients on the stability of ascorbic acid (vitamin c) tablets.
    Ofoefule SI; Chukwube VO; Attama AA
    Boll Chim Farm; 1999 Sep; 138(8):418-21. PubMed ID: 10622107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.